Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 27.31 Delayed Data As of Dec 08 |  +0.13 / +0.48%Today’s Change | 20.83 Today|||52-Week Range 30.22 | +17.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 95.7M | 153.2M | 118.7M | 146.6M | |
| Short Term Investment Cash | 94.1M | 57.5M | -34.5M | 27.8M | ||
| Cash & Short Term Investments | 95.7M | 153.2M | 118.7M | 146.6M | ||
| Receivables | Receivables | 0.00 | 2.1M | 10.0M | 77.9M | |
| Inventories | Inventories | 0.00 | 1.3M | 1.8M | 7.8M | |
| Current Assets | Prepaid Expenses | 628.0K | 1.6M | 2.5M | 4.1M | |
| Other Current Assets | 205.0K | 304.0K | 456.0K | 1.0M | ||
| Current Assets | 96.5M | 158.6M | 133.5M | 237.5M | ||
| Total Assets | Property, Plant and Equipment - Gross | 1.8M | 2.4M | 3.5M | 11.1M | |
| Depreciation | -1.1M | -1.3M | -1.7M | -1.8M | ||
| Intangible Assets | 0.00 | 2.1M | 0.00 | 44.3M | ||
| Other Assets | 353.0K | 2.3M | 161.0K | 44.5M | ||
| Total Assets | 97.7M | 162.0M | 135.6M | 291.2M | ||
| Liabilities | Accounts Payable | 0.00 | 9.1M | 5.7M | 12.2M | |
| Short Term Debt | 2.7M | 2.7M | 1.5M | 1.6M | ||
| Accrued Expenses | 632.0K | 4.3M | 18.2M | 167.4M | ||
| Other Current Liabilities | 4.2M | 9.2M | 18.2M | 167.7M | ||
| Other Liabilities | 8.4M | 25.6M | 31.5M | 189.1M | ||
| Total Liabilities | Long Term Debt | 4.1M | 1.5M | 0.00 | 9.9M | |
| Other Liabilities | 68.0K | 34.0K | 0.00 | 676.0K | ||
| Total Liabilities | 12.6M | 27.1M | 31.5M | 199.7M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 85.1M | 134.9M | 104.1M | 91.6M | ||
| Total Shareholder Equity | 85.1M | 134.9M | 104.1M | 91.6M | ||
| Share Information | Common Shares Outstanding | 20.7M | 29.4M | 32.8M | 33.3M | |
| Addtl. Info. | No data currently available for this section. | |||||
